Life Science & Biotech Companies in Cambridge

Ultra-fast PCR point-of-care diagnostics from swab to result

LEX Diagnostics is a molecular diagnostics company developing rapid point-of-care PCR testing through its proprietary thermal cycling platform. Its system delivers quantitative…

Global population genomics platform for drug target discovery and clinical trials

Omnigen Biodata is a biotechnology company operating the Discover Me platform, a global population health and genomics research programme integrating health and genetic data from…

Proprietary formulation platform enhancing diabetes and cardiometabolic therapies

Arecor Therapeutics is a biopharmaceutical company developing enhanced formulations of existing therapeutic products for diabetes and cardiometabolic diseases. Its proprietary…

Ocean-microbe fermentation platform for sustainable biosurfactants in personal care

BravelyCultured is a UK-based biotechnology company developing sustainable, biodegradable chemicals using ocean-based microorganisms and fermentation. The company's current focus…

Non-invasive small molecule eye drops for retinal vascular disease

Foventa is a biopharmaceutical company developing non-invasive, small molecule therapeutics for retinal vascular diseases that can cause vision loss. Its lead candidate targets…

Rare disease partnering platform connecting patient groups with drug developers

Aspire Biosciences is a Cambridge-based company accelerating treatment development for rare and unaddressed diseases through its Systematic Serendipity methodology. The company…

Ultra-high-throughput biologics discovery platform powered by generative AI

Sortera Bio is a biotechnology company developing an AI-powered platform for the discovery and engineering of biological therapeutics. The Deep Screening platform generates…

Immunotherapies targeting blood cancer precursor conditions before onset

Athernal Bio is a Cambridge-based biotechnology company developing targeted immunotherapies for high-risk clonal haematopoiesis, a widespread blood stem cell mutation condition…

AI and multi-omics platform for cardiovascular drug target discovery

CardiaTec Biosciences is a Cambridge-based biotech applying artificial intelligence to large-scale multi-omic data to identify novel drug targets for cardiovascular diseases. Its…

AI-powered cell simulation platform targeting ageing and age-driven diseases

Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation. Its proprietary…

Point-of-care molecular diagnostic platform for rapid infectious disease detection

Diagnostics for the Real World (Europe) is a Cambridge University spin-out developing and commercialising a fully automated point-of-care molecular diagnostic system for rapid…

Synthetic VHH antibody libraries and discovery services

Isogenica is a contract discovery company specialising in VHH single-domain antibody discovery, offering what it describes as the world's largest synthetic VHH library alongside…